Pharmacological characterization of [³H]CHIBA-3007 binding to glycine transporter 1 in the rat brain - Wikidata - awgldk - TriplyDB

Pharmacological characterization of [³H]CHIBA-3007 binding to glycine transporter 1 in the rat brain

Pharmacological characterization of [³H]CHIBA-3007 binding to glycine transporter 1 in the rat brain

http://www.wikidata.org/entity/Q33952310

about

Relationship between glycine transporter 1 inhibition as measured with positron emission tomography and changes in cognitive performances in nonhuman primates In Vivo Evaluation of (11)C-labeled Three Radioligands for Glycine Transporter 1 in the Mouse Brain Inhibition of glycine transporter-1 in the dorsal vagal complex improves metabolic homeostasis in diabetes and obesity.Overview of the detection methods for equilibrium dissociation constant KD of drug-receptor interaction.

P2860

Q34357077-C818FFB5-6D80-4E92-BE06-A9D8ABC84020 Q36600827-B7ABD236-62BC-4294-B53E-802B1D76A746 Q37434371-030B43AA-C2B0-46C1-8090-3272D10AB69D Q55386462-B475FD18-823A-40A4-85C6-C9B23086E9AA

P2860

Pharmacological characterization of [³H]CHIBA-3007 binding to glycine transporter 1 in the rat brain

http://www.wikidata.org/entity/Q33952310

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Pharmacological characterizati ...... transporter 1 in the rat brain

@ast

Pharmacological characterizati ...... transporter 1 in the rat brain

@en

type

label

Pharmacological characterizati ...... transporter 1 in the rat brain

@ast

Pharmacological characterizati ...... transporter 1 in the rat brain

@en

prefLabel

Pharmacological characterizati ...... transporter 1 in the rat brain

@ast

Pharmacological characterizati ...... transporter 1 in the rat brain

@en

P1433

Q33952310-90884CD6-53DC-49E7-AFF9-35DD12C1AF17

P1476

Q33952310-7B82A8B8-F689-4EDD-8405-1CA1847A300D

P2093

Q33952310-2EC71D93-D94F-43E8-9BCB-980F31CD7AE3

Q33952310-33739DF6-F890-49DB-9D8A-FACC86442AA2

Q33952310-3EB36F7A-5435-4750-B5E7-6CE75C11F7F9

Q33952310-890FF063-9D51-4C3F-B0D2-05015D7FD6A4

Q33952310-997525AE-E3B1-441E-9A2A-A7E604E1BBC1

Q33952310-B284D0B5-8112-4440-94EA-45BFB14498CF

P2860

Q33952310-0AEFCE41-7B42-475E-8516-7FC7503AB529

Q33952310-0BBFD70D-6AD8-4B9C-8150-FF0A44E098F9

Q33952310-0BCD81FB-7E82-45D2-BC87-6472EB4D297A

Q33952310-11E4D389-CDDB-4F4D-B3B3-62F7508F0FF6

Q33952310-1C629712-CFAA-4CD9-9EE8-ADEA7D7DF960

Q33952310-2155B5C6-A6F7-45F4-8BA9-D51CD141DF1C

Q33952310-22F81DF4-3177-4F6A-86C2-AF1ACC479FBC

Q33952310-288BC210-307C-4C59-BD18-9E9C29901757

Q33952310-28A62A46-606B-42DB-8B91-663125C85DF0

Q33952310-2AF24982-AF69-4D55-858D-D2463E8C0979

P304

Q33952310-DEEEF01A-C8AF-406A-A178-4B247196E73D

P31

Q33952310-76CA90DB-A87E-4DC5-A9BE-9F976AA8CE84

P356

Q33952310-4B421C67-8B0F-47BC-B435-56BBFB28B3F5

P407

Q33952310-95F7B113-3C2D-427B-9C70-C36F47440B31

P433

Q33952310-A9D935BA-CB56-40E1-B64F-095D72D76B9B

P478

Q33952310-22373B30-9A06-4F86-A810-E4959F0BA952

P577

Q33952310-F949B06E-2DD2-4DA9-9F5D-49FC1D6B5EC5

P5875

Q33952310-FB05BA6B-8D8B-442E-A794-9B986F15869B

P698

Q33952310-943A22DD-47AA-40EF-9F69-7A22B2C45288

P932

Q33952310-EAB49CDE-E9F7-4FAB-9AEE-D479704734E9

P356

JOURNAL.PONE.0021322

P1433

P1476

Pharmacological characterizati ...... transporter 1 in the rat brain

@en

P2093

Hongxian Chen

http://www.w3.org/2001/XMLSchema#string

Jichun Zhang

http://www.w3.org/2001/XMLSchema#string

Jin Wu

http://www.w3.org/2001/XMLSchema#string

Jun Toyohara

http://www.w3.org/2001/XMLSchema#string

Kenji Hashimoto

http://www.w3.org/2001/XMLSchema#string

Yuko Fujita

http://www.w3.org/2001/XMLSchema#string

P2860

Cloning of the human glycine transporter type 1: molecular and pharmacological characterization of novel isoform variants and chromosomal localization of the gene in the human and mouse genomes

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

Cloning and expression of a glycine transporter reveal colocalization with NMDA receptors

Recent advances in the phencyclidine model of schizophrenia

Glycine transport inhibitors for the treatment of schizophrenia

Decreased serum levels of D-serine in patients with schizophrenia: evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia.

The emerging role of glutamate in the pathophysiology and treatment of schizophrenia.

Two glycine transporter variants with distinct localization in the CNS and peripheral tissues are encoded by a common gene.

Pharmacology and expression analysis of glycine transporter GlyT1 with [3H]-(N-[3-(4'-fluorophenyl)-3-(4'phenylphenoxy)propyl])sarcosine.

Glycine transporters: essential regulators of neurotransmission.

P304

e21322

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0021322

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2011-06-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51469740

http://www.w3.org/2001/XMLSchema#string

P698

21731704

http://www.w3.org/2001/XMLSchema#string

P932

3121759

http://www.w3.org/2001/XMLSchema#string